| 1 |
34793719 | Evorpacept alone and in combination with pembrolizumab or trastuzumab in patients with advanced solid tumours (ASPEN-01): a first-in-human, open-label, multicentre, phase 1 dose-escalation and dose-expansion study. | 2021 Dec |
1 |
| 2 |
32820530 | Assessing and mitigating the interference of ALX148, a novel CD47 blocking agent, in pretransfusion compatibility testing. | 2020 Oct |
2 |
| 3 |
30133535 | ALX148 blocks CD47 and enhances innate and adaptive antitumor immunity with a favorable safety profile. | 2018 |
3 |